Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin - Egyptian Knowledge Bank

41925

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Thesis

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Thesis

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Thesis

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

Thesis

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Thesis

Non-invasive prediction of oesophageal varices with FibroScan and Doppler U/S in HCV patients with cirrhosis

Thesis

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

Thesis

Biochemical markers of liver fibrosis in HCV patients

Thesis

Towards a scoring system depending on laboratory and ultrasound findingsfor the detection of hepatic fibrosis in chronic HCV infected patients

Thesis

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study